Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant

American Journal of Transplantation

Volumn 12, Issue 2, 2012, Pages 438-446

  Neujahr, D C ^a   Perez, S D ^a   Mohammed, A ^a   Ulukpo, O ^a   Lawrence, E C ^a   Fernandez, F ^a   Pickens, A ^a   Force, S D ^a   Song, M ^a   Larsen, C P ^a   Kirk, A D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Area under curve; bronchiolitis obliterans; bronchoalveolar lavage; chemokines; lung transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; RANTES; TACROLIMUS;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN INDUCTION; SAMPLE;

ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL10; CHEMOKINE CXCL9; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERFERON-GAMMA; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84856432625     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03857.x     Document Type: Article

References (20)

1. Christie JD, Edwards LB, Aurora P, et al,. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth official adult lung and heart-lung transplantation report-2009. J Heart Lung Transplant 2009; 28: 1031-1049.
2. Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Lynch JP, Belperio JA,. Chronic allograft rejection: Epidemiology, diagnosis, pathogenesis, and treatment Semin Respir Crit Care Med. 2010; 31: 189-207.
3. Glanville AR,. Bronchoscopic monitoring after lung transplantation Semin Respir Crit Care Med. 2010; 31: 208-221.
4. Agostini C, Calabrese F, Rea F, et al,. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 1703-1711. (Pubitemid 32422935)
5. Belperio JA, Keane MP, Burdick MD, et al,. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169: 1037-1049. (Pubitemid 34753464)
6. Belperio JA, Keane MP, Burdick MD, et al,. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 2003; 171: 4844-4852. (Pubitemid 37310606)
7. Keane MP, Gomperts BN, Weigt S, et al,. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. J Immunol 2007; 178: 511-519. (Pubitemid 46033635)
8. Belperio JA, Keane MP, Burdick MD, et al,. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 2001; 108: 547-556. (Pubitemid 32777734)
9. Flesch-Janys D, Steindorf K, Gurn P, Becher H,. Estimation of the cumulated exposure to polychlorinated dibenzo-p-dioxins/furans and standardized mortality ratio analysis of cancer mortality by dose in an occupationally exposed cohort. Environ Health Perspect 1998; 106 (Suppl 2): 655-662. (Pubitemid 28256773)
10. Frost-Pineda K, Liang Q, Liu J, et al,. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 2011; 3: 182-193.
11. Maskarinec G, Pagano I, Lurie G, Kolonel LN,. A longitudinal investigation of mammographic density: The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006; 15: 732-739.
12. Stevens TP, Dylag A, Panthagani I, Pryhuber G, Halterman J,. Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol 2010; 45: 371-379.
13. Ling Y, Pong T, Vassiliou CC, Huang PL, Cima MJ,. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol 2011; 3: 273-237.
14. Harris S, Coupes BM, Roberts SA, Roberts IS, Short CD, Brenchley PE,. TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol 2007; 20: 177-185. (Pubitemid 47072401)
15. Burlingham WJ, Love RB, Jankowska-Gan E, et al,. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498-3506. (Pubitemid 350097005)
16. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al,. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8: 1911-1920.
17. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al,. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27: 779-787. (Pubitemid 44914203)
18. Sadeghi M, Daniel V, Naujokat C, et al,. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients. Clin Transplant 2010; 24: 415-423.
19. Mertens M, Singh JA,. Anakinra for rheumatoid arthritis: A systematic review. J Rheumatol 2009; 36: 1118-1125.
20. Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA,. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 2008; 177: 1033-1040. (Pubitemid 351717599)